Paper
8 February 2011 Folate receptor targeted Type 1 photosensitizer bioconjugates for tumor visualization and phototherapy
Raghavan Rajagopalan, Amruta R. Poreddy, Amolkumar Karwa, Bethel Asmelash, Nicole E. Putnam, Lori Chinen, Maureen Nichols, J. Jeng Shieh, Richard B. Dorshow
Author Affiliations +
Abstract
Folate receptors are over expressed in many types of cancers, including, ovarian, breast, and cervical. In our continuing efforts toward the development of targeted Type 1 phototherapeutic agents, an azide-based Type 1 photosensitizer and a pyrzine-based fluorophore that absorb and emits in the visible region, and a dual diagnostic-therapeutic probe consisting of the fluorophore and the photosensitizer were prepared and independently conjugated to two folate receptor specific vectors: γ-carboxyl-modified folic acid and anti-human FOLR1 (folate receptor-1) antibody In vitro receptor binding study showed that all the conjugates had high (ca 1-7 nM) affinity to the folate receptor. Confocal microscopy images indicated that the pyrazine conjugates were selectively taken up by the folate receptor expressing ovarian cancer KB cells.
© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Raghavan Rajagopalan, Amruta R. Poreddy, Amolkumar Karwa, Bethel Asmelash, Nicole E. Putnam, Lori Chinen, Maureen Nichols, J. Jeng Shieh, and Richard B. Dorshow "Folate receptor targeted Type 1 photosensitizer bioconjugates for tumor visualization and phototherapy", Proc. SPIE 7886, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XX, 78860D (8 February 2011); https://doi.org/10.1117/12.875166
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Receptors

Confocal microscopy

Photosensitizer targeting

Cancer

Sensors

Ovarian cancer

Photodynamic therapy

Back to Top